Latest news:
The 50 “companies-for-the-future” this year – BioReperia is one of the finalists in Techarenan Challenge 2021!
Read more
/

New article published

Zebrafish can predict lymph node involvement and treatment outcome in non-small cell lung cancer

The ZTX platform provide a fast, accurate, and clinically relevant system for evaluation of treatment outcome and invasion/dissemination of PDX models, providing an attractive platform for combined mouse-zebrafish PDX trials and personalized medicine.
Read the full article here https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827197/